Implants News and Research

RSS

DSM announces agreements with Biomedical Structures, Cortland and Secant Medical

DSM, which created and manufactures Dyneema Purity, the world's strongest Medical grade fiber, today announced agreements with Biomedical Structures, Cortland Company and Secant Medical. These companies' experience in processing Dyneema Purity fiber in biomedical textile structures offers medical device companies the ability to use various constructions of Dyneema Purity, including the recently launched Dyneema Purity BLUE, in commercial medical devices.

9 Jun 2010

Integra LifeSciences announces over 800 implantations of Vu a-POD fusion device

Integra LifeSciences announced today a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been implanted in over 800 patients in the U.S.

8 Jun 2010

Biomet Biologics initiates enrollment in MarrowStim P.A.D. Kit IDE trial for critical limb ischemia

Biomet, a global leader in the manufacture of orthopedic and biotechnology products, announced today that its subsidiary, Biomet Biologics, has enrolled the first subject into its multicenter, prospective, randomized, double-blind, placebo-controlled clinical trial for critical limb ischemia (CLI).

5 Jun 2010

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.

4 Jun 2010

Two-stage procedure reduces bone loss in oral implants

Researchers have found that less bone loss is experienced in an oral implant when a two-stage approach to surgery is used. Simultaneously inserted implants, which require one operation to transplant bone tissue and to insert implants into the jawbone, have shown excellent results. However, when the implants were inserted in a second operation about six months after the bone tissue grafts, crestal bone loss was reduced.

4 Jun 2010

Amedica secures US patent for novel hip implant

Amedica Corporation, a spinal and orthopaedic implant and instrument manufacturer focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted United States Patent No. 7,695,521 covering its novel hip implant featuring a monoblock ceramic acetabular cup for use in articulating joints for total joint replacement.

3 Jun 2010

IDC to provide new software package for Orthopaedic DR Customers

IDC, today announced that it has signed an agreement with Merge Healthcare Inc. to provide their ProPlanner software package to IDC's growing number of Orthopaedic digital radiography (DR) customers.

3 Jun 2010

Latinos have highest rates of eye disease: New research

New research suggests Latinos have the highest rates of eye disease in the United States, and one Los Angeles area clinic, Eye Physicians of Long Beach, is supremely prepared to meet the community's eye care needs.

2 Jun 2010

AAID's advice on teeth suddenly knocked out

Chicago Blackhawks star Duncan Keith's dental misfortune on the ice is an occupational hazard for hockey players, but teeth also can be lost in accidents, sports mishaps and falls that can happen to anyone. So what should you do when one or more of your teeth are suddenly knocked out?

29 May 2010

Sutter General performs first hip replacement with ROBODOC Surgical System after FDA clearance

Eighteen years ago, orthopedic surgeon William Bargar, M.D. made history when, at Sutter General Hospital in Sacramento, he performed the first-ever hip replacement using a robotic device he developed called ROBODOC®, which improves precision in joint replacement surgery. Warren Roberts of Davis was among Dr. Bargar's first patients; in 1995, he underwent replacement of his left hip as a part of an FDA study using ROBODOC®.

29 May 2010

DFG approves establishment of twelve new CRCs

The Deutsche Forschungsgemeinschaft has approved the establishment of twelve new Collaborative Research Centres beginning 1 July 2010. This was decided by the responsible Grants Committee at its spring meeting in Bonn. The new CRCs will initially be funded for four years with a total of 112 million euros (including a 20% programme allowance for indirect project costs).

29 May 2010

Orthopedic surgeons plan to reduce usage of metal-on-metal hip implants: Survey

Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that 25% of the 150 orthopedic surgeons surveyed in its newest Physician Forum publication plan to reduce their usage of metal-on-metal hip implants over the next twelve months.

28 May 2010

Osprey Biomedical rolls out Eagle Cervical Allograft Series in ATPS Preservation System

Osprey Biomedical, a global spinal allograft bio-implant company announced today it has begun the roll out of its Eagle Cervical Allograft Series being offered in its ATPS Preservation System.

28 May 2010

Uroplasty reports strong sales growth for Macroplastique in fourth-quarter 2010

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fourth fiscal quarter and full year ended March 31, 2010. The results were highlighted by continued strong U.S. sales growth for Macroplastique and a reduction in operating and net loss compared to the prior year.

28 May 2010

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat serious acute cardiovascular disorders and infectious diseases, has received a grant in the amount of $150,000 from the National Science Foundation to support the development of antimicrobial sutures. PolyMedix has developed a series of novel antimicrobial polymers for device and material applications, which it collectively calls the PolyCides™.

27 May 2010

Computer virus infects scientist

A scientist at the University of Reading has become the first person in the world to be infected by a computer virus.

27 May 2010

Abbott reports positive 6-month results from bioresorbable vascular scaffold trial at EuroPCR 2010

Abbott today announced positive six-month results from the first 45 patients enrolled in the second stage of the ABSORB trial, which was presented during the Late-Breaking Clinical Trials session at the EuroPCR 2010 conference. At six months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results, with a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots (thromboses).

26 May 2010

6-month results of NovoStent's SAMBA trial for atherosclerotic disease in SFA and popliteal arteries

NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.

26 May 2010

Stryker, Acuitec form strategic relationship

Stryker’s Communications business unit and Acuitec announced today that they have signed an agreement that will integrate both companies’ technologies within the operating room to provide customers with a comprehensive offering that combines in-room integration with desirable workflow solutions.

From Stryker 25 May 2010

Arthrosurface achieves significant clinical milestone in implant technology

Arthrosurface, Inc., the developer of inlay joint resurfacing systems, announced the achievement of a significant clinical milestone.

25 May 2010

Implants News and Research

DSM announces agreements with Biomedical Structures, Cortland and Secant Medical

Integra LifeSciences announces over 800 implantations of Vu a-POD fusion device

Biomet Biologics initiates enrollment in MarrowStim P.A.D. Kit IDE trial for critical limb ischemia

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Two-stage procedure reduces bone loss in oral implants

Amedica secures US patent for novel hip implant

IDC to provide new software package for Orthopaedic DR Customers

Latinos have highest rates of eye disease: New research

AAID's advice on teeth suddenly knocked out

Sutter General performs first hip replacement with ROBODOC Surgical System after FDA clearance

DFG approves establishment of twelve new CRCs

Orthopedic surgeons plan to reduce usage of metal-on-metal hip implants: Survey

Osprey Biomedical rolls out Eagle Cervical Allograft Series in ATPS Preservation System

Uroplasty reports strong sales growth for Macroplastique in fourth-quarter 2010

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

Computer virus infects scientist

Abbott reports positive 6-month results from bioresorbable vascular scaffold trial at EuroPCR 2010

6-month results of NovoStent's SAMBA trial for atherosclerotic disease in SFA and popliteal arteries

Stryker, Acuitec form strategic relationship

Arthrosurface achieves significant clinical milestone in implant technology

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News